- Static Telepathology
- Dynamic Telepathology
- Hybrid Telepathology
Telepathology Market size was valued at USD 645.37 million in 2021 and is expected to reach a value of USD 1,788 million by 2028, at a CAGR of 12.15% during the forecast period 2022 and 2028. Telepathology referred as practising pathology from a distance and telecommunication technology is used for facilitating the transmission of pathology image rich data between two distant locations for diagnosis, research and education. Pathology plays a very important role in identifying the characteristics and causes of the diseases in medical field. Electronic medical records also increase the administrative efficiency and reduces the medical cost. There are three modes of telepathology are static (or store-and-forward), dynamic (or real-time) and hybrid (or virtual. Static telepathology refers to the process of pre-selection and digitalisation of representative image by sender pathologist and sending it to the remote pathologist via e-mail or internet. Dynamic telepathology is most appropriate system for frozen-selection telepathology and for understaffed area. This involves transmission of microscopic slide images to recipient in real time via live communication. Whereas, hybrid pathology is combining both static and dynamic telepathology modes, a series of images that automatically stitched together in a software, compressed to a single file form and transmitted on the dynamic telepathology session start. Telepathology Market is technology-driven segment of medical field. It is an innovative digital imaging and telecommunication technology that is changing the healthcare delivery systems globally. The regional players are involving in acquisition of the pathology providers that present locally and strengthening their position in market. For instance, in November 2016, Visiopharm A/S acquired LRI Imaging AB, a leading diagnostic digital pathology provider in Sweden to become leader in diagnostic digital pathology. Similarly, in June 2016, Philips acquired an Irish digital pathology firm, PathXL and its digital pathology imaging technology. By this acquisition, Philips seeks to accelerate drive to support global medical institutions and their transition to digitalize workflows.
Fastest Growing Market
The Market is driven by the technological advancements, digitalization of pathology. In addition, extended reach, cost-effectiveness of the services and quick diagnosis are expected to bolster the global telepathology market over the forecast period. Furthermore, ease of operation, increase in government funding for hospitals and growing demand for telemedicine are also expected to further boost the market growth during the forecast period. However, factors such as the high cost of devices, lack of skilled professionals, and lack of infrastructure in underdeveloped and developing countries expected to hamper the market growth over the forecast period. Moreover, monitoring of telepathology requires high amount of investment and errors in interpreting the digital data may act as restraints for the market growth.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.